In various cancer types, the infiltration of immune cell populations has shown diverse prognostic outcomes, with immune cell types such as CD8 + T cells, B cells, CD4 + T cells, and neutrophil-macrophage dendritic cells playing crucial roles in the progression of specific tumors and influencing the response to immunotherapy [57–59]. This evidence concerns the gene CD4 and cancer.